Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Owen P. Faris"'
Autor:
Jeffrey Shuren, Owen P. Faris
Publikováno v:
New England Journal of Medicine. 376:1350-1357
Medical devices range from something as simple as an elastic bandage to something as complicated as a deep-brain stimulator. This review describes the FDA approach for understanding and approving medical devices.
Autor:
Owen P. Faris, Raimond L. Winslow, David A. Kass, Patrick A. Helm, Laurent Younes, Daniel B. Ennis, Elliot R. McVeigh, Michael I. Miller, Christophe Leclercq, Mirza Faisal Beg
Publikováno v:
Circulation Research. 98:125-132
Ventricular remodeling of both geometry and fiber structure is a prominent feature of several cardiac pathologies. Advances in MRI and analytical methods now make it possible to measure changes of cardiac geometry, fiber, and sheet orientation at hig
Publikováno v:
Journal of the American College of Cardiology. 46(12):2325-2328
Cardiac resynchronization therapy (CRT) devices have been studied clinically since 1998, and have been on the U.S. market since the Food and Drug Administration (FDA) approval of the first product in 2001. Since that time, the FDA has approved many d
Autor:
K. Smits, Theo Arts, Peter H. M. Bovendeerd, Elliot R. McVeigh, Frits W. Prinzen, Roy C. P. Kerckhoffs, Owen P. Faris
Publikováno v:
American Journal of Physiology : Heart and Circulatory Physiology, 289(5), H1889-H1897. American Physiological Society
Intraventricular synchrony of cardiac activation is important for efficient pump function. Ventricular pacing restores the beating frequency but induces more asynchronous depolarization and more inhomogeneous contraction than in the normal heart. We
Publikováno v:
Congestive Heart Failure. 11:207-211
Cardiac resynchronization therapy and ventricular assist devices are two of the many US Food and Drug Administration-regulated medical device technologies that are intended for patients with heart failure. Cardiac resynchronization therapy devices ha
Autor:
Alexander Dick, Elliot R. McVeigh, Owen P. Faris, David A. Kass, Venkatesh K. Raman, Daniel B. Ennis, Frank Evans
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 285:H1864-H1870
Cardiac resynchronization therapy has been most typically achieved by biventricular stimulation. However, left ventricular (LV) free-wall pacing appears equally effective in acute and chronic clinical studies. Recent data suggest electrical synchrony
Autor:
Morteza Loghmani, Gordon F. Tomaselli, David A. Kass, Richard S. Tunin, Elliot R. McVeigh, David D. Spragg, Owen P. Faris, Christophe Leclercq, Deborah DiSilvestre
Publikováno v:
Circulation. 108:929-932
Background— Left ventricular (LV) mechanical dyssynchrony induces regional heterogeneity of mechanical load and is an independent predictor of mortality and sudden death in heart failure (HF) patients. We tested whether dyssynchrony also induces lo
Publikováno v:
Journal of Electrocardiology. 35:61-64
Methods currently exist for the precise measurement of local three-dimensional myocardial motion noninvasivly with magnetic resonace imaging tagging. From these motion estimates, strain images representing the local deformation of the myocardium can
Publikováno v:
Device Therapy in Heart Failure ISBN: 9781588299949
The Food and Drug Administration’s Center for Devices and Radiological Health (CDRH) is charged with ensuring that manufacturers of new medical devices demonstrate a reasonable assurance that their devices are safe and effective prior to approval f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d1198d6d3b523e037dbbda10253234d
https://doi.org/10.1007/978-1-59745-424-7_4
https://doi.org/10.1007/978-1-59745-424-7_4
Autor:
Owen P. Faris, Mitchell J. Shein
Publikováno v:
Circulation. 114(12)
In April 2005, the US Food and Drug Administration (FDA) commented on the current research regarding the use of magnetic resonance imaging (MRI) on patients with a pacemaker or implantable cardioverter-defibrillator (ICD).1 Pacemaker and ICD labeling